2,181 followers
"One obvious disadvantage of [Blinatumomab] is the requirement for continuous IV infusion because of the small molecular weight and..." 1/2 https://t.co/6k4eu1dcPB
"One obvious disadvantage of [Blinatumomab] is the requirement for continuous IV infusion because of the small molecular weight and..." 1/2 https://t.co/6k4eu1dcPB
Blinatumomab: a bispecific T cell engager (BiTE) antibody against CD19/CD3 for refractory acute lymph... https://t.co/CTYaIISRkk #jhoonline
Blinatumomab: a bispecific T cell engager (BiTE) antibody against CD19/CD3 for refractory acute lymph... https://t.co/CTYaIISRkk #jhoonline
Blinatumomab: a bispecific T cell engager (BiTE) antibody against CD19/CD3 for refractory acute lymphoid leukemia.… http://t.co/GN0yqHhI48